39670dkk
-0,3 %
Date:2025-09-17Time:16:59:46Latest report:Q4-2023List:Large CapTicker:NSIS B
Market Cap:185 774 mdkkEnterprise Value:192 439 mdkkNet Sales:17 899 mdkkEarnings:3 024 mdkkEmployees:0ISIN:DK0060336014
Ratios
10-year key figure history for Novonesis turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for Novonesis with index and moving average MA50 and MA200.
Stockprice:396,70
MA50:420,71
MA200:423,29
Price/MA200:-6,3 %
RSI (14):37,6
Price/MA50:-5,7 %
Description
Novonesis is a biochemistry company. The company develops enzymes and various microorganisms for industrial use. The enzymes are a protein used in a number of different industries, mainly in the agricultural and food industries. Novonesis products are used in various foods and clothing and the company holds sales on a global level. Novonesis was founded in 1921 and is headquartered in Bagsværd, Denmark.
Chemicals
1 week
1 month
aXichem
-12,8 %
41,6 %
Nexam Chemical
5,5 %
8,0 %
Trelleborg
0,7 %
6,5 %
Nolato
-0,1 %
5,8 %
Aspo
4,5 %
4,5 %
Hexpol
0,8 %
3,0 %
SP Group
-0,5 %
3,0 %
Rias
-1,5 %
1,6 %
Kemira
-1,3 %
-0,5 %